US Stock MarketDetailed Quotes

ALDX Aldeyra Therapeutics

Watchlist

3.950
-0.140-3.42%

Close May 17 16:00 ET

3.920
-0.030-0.76%

Post 17:10 ET

234.69MMarket Cap-7745P/E (TTM)

Aldeyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-5.60%-9.97M

46.46%-30.33M

104.46%500.44K

36.18%-8.02M

33.07%-13.36M

26.64%-9.44M

-33.09%-56.64M

2.99%-11.23M

-49.09%-12.57M

-119.99%-19.96M

Net income from continuing operations

48.24%-8.08M

39.47%-37.54M

63.16%-4.75M

43.75%-8.19M

49.46%-8.99M

6.98%-15.62M

-7.35%-62.02M

18.11%-12.9M

7.86%-14.55M

-19.04%-17.78M

Depreciation and amortization

-9.47%60.63K

1.57%262.78K

-0.26%66.47K

-0.48%65K

0.51%64.34K

6.74%66.97K

-2.07%258.71K

8.77%66.64K

-4.45%65.31K

-4.02%64.01K

Other non cash items

-33.28%58.15K

6.96%354.19K

-14.51%70.75K

15.87%95.94K

21.19%100.34K

5.27%87.16K

-19.13%331.15K

-0.06%82.75K

0.00%82.8K

-19.12%82.8K

Change In working capital

-283.85%-3.39M

125.00%861.18K

562.65%5.92M

-103.09%-788.2K

-69.07%-6.11M

0.31%1.84M

-146.30%-3.44M

-141.95%-1.28M

-106.70%-388.1K

-207.16%-3.61M

-Change in prepaid assets

-175.57%-2.82M

146.14%1.73M

56.70%-1.11M

29.40%-71.57K

-156.70%-814.44K

247.73%3.73M

-267.94%-3.76M

-205.20%-2.57M

-109.63%-101.37K

-33.96%1.44M

-Change in payables and accrued expense

70.12%-565.05K

-2,273.11%-6.87M

-20.23%1.03M

-149.93%-716.63K

-4.85%-5.29M

-143.35%-1.89M

-93.92%316.31K

112.53%1.29M

-106.05%-286.74K

-521.83%-5.05M

-Change in other working capital

----

--6M

----

Cash from discontinued investing activities

Operating cash flow

-5.60%-9.97M

46.46%-30.33M

104.46%500.44K

36.18%-8.02M

33.07%-13.36M

26.64%-9.44M

-33.09%-56.64M

2.99%-11.23M

-49.09%-12.57M

-119.99%-19.96M

Investing cash flow

Cash flow from continuing investing activities

-201.26%-30.38M

200.15%30M

151.70%30M

-383,637.25%-29.95M

27M

19.02M

-17.94M

Net PPE purchase and sale

----

--0

----

-109.03%-16.32K

--0

Net investment purchase and sale

-201.26%-30.38M

200.21%30M

--0

151.71%30M

---29.94M

--27M

--19.02M

---17.94M

Cash from discontinued investing activities

Investing cash flow

-201.26%-30.38M

200.15%30M

--0

151.70%30M

-383,637.25%-29.95M

--27M

--19.02M

---17.94M

Financing cash flow

Cash flow from continuing financing activities

-65.39%18.19K

-204.11%-1.27M

-1.01M

-126.38%-315.76K

5.29K

125.34%52.56K

-99.37%1.22M

1,776.46%1.2M

Proceeds from stock option exercised by employees

-65.39%18.19K

-74.98%305.23K

--30.19K

-81.85%217.19K

--5.29K

125.34%52.56K

-73.96%1.22M

--0

1,776.46%1.2M

--0

Net other financing activities

----

---1.58M

---1.04M

----

Cash from discontinued financing activities

Financing cash flow

-65.39%18.19K

-204.11%-1.27M

---1.01M

-126.38%-315.76K

--5.29K

125.34%52.56K

-99.37%1.22M

--0

1,776.46%1.2M

--0

Net cash flow

Beginning cash position

-1.11%142.82M

-37.15%144.42M

11.41%143.33M

25.34%151.68M

3.85%165.03M

-37.15%144.42M

195.14%229.79M

-46.70%128.65M

-51.54%121.01M

14.78%158.91M

Current changes in cash

-295.70%-40.33M

98.13%-1.6M

-103.25%-511.87K

-209.19%-8.34M

64.77%-13.35M

129.07%20.61M

-156.19%-85.37M

236.20%15.77M

191.26%7.64M

-134.05%-37.9M

End cash Position

-37.89%102.49M

-1.11%142.82M

11.41%143.33M

25.34%151.68M

3.85%165.03M

-37.15%144.42M

-46.70%128.65M

-51.54%121.01M

Free cash flow

-5.60%-9.97M

46.47%-30.33M

104.46%500.44K

36.18%-8.02M

33.07%-13.36M

26.73%-9.44M

-33.10%-56.65M

2.99%-11.23M

-49.09%-12.57M

-119.99%-19.96M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-5.60%-9.97M	46.46%-30.33M	104.46%500.44K	36.18%-8.02M	33.07%-13.36M	26.64%-9.44M	-33.09%-56.64M	2.99%-11.23M	-49.09%-12.57M	-119.99%-19.96M
Net income from continuing operations	48.24%-8.08M	39.47%-37.54M	63.16%-4.75M	43.75%-8.19M	49.46%-8.99M	6.98%-15.62M	-7.35%-62.02M	18.11%-12.9M	7.86%-14.55M	-19.04%-17.78M
Depreciation and amortization	-9.47%60.63K	1.57%262.78K	-0.26%66.47K	-0.48%65K	0.51%64.34K	6.74%66.97K	-2.07%258.71K	8.77%66.64K	-4.45%65.31K	-4.02%64.01K
Other non cash items	-33.28%58.15K	6.96%354.19K	-14.51%70.75K	15.87%95.94K	21.19%100.34K	5.27%87.16K	-19.13%331.15K	-0.06%82.75K	0.00%82.8K	-19.12%82.8K
Change In working capital	-283.85%-3.39M	125.00%861.18K	562.65%5.92M	-103.09%-788.2K	-69.07%-6.11M	0.31%1.84M	-146.30%-3.44M	-141.95%-1.28M	-106.70%-388.1K	-207.16%-3.61M
-Change in prepaid assets	-175.57%-2.82M	146.14%1.73M	56.70%-1.11M	29.40%-71.57K	-156.70%-814.44K	247.73%3.73M	-267.94%-3.76M	-205.20%-2.57M	-109.63%-101.37K	-33.96%1.44M
-Change in payables and accrued expense	70.12%-565.05K	-2,273.11%-6.87M	-20.23%1.03M	-149.93%-716.63K	-4.85%-5.29M	-143.35%-1.89M	-93.92%316.31K	112.53%1.29M	-106.05%-286.74K	-521.83%-5.05M
-Change in other working capital	----	--6M	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-5.60%-9.97M	46.46%-30.33M	104.46%500.44K	36.18%-8.02M	33.07%-13.36M	26.64%-9.44M	-33.09%-56.64M	2.99%-11.23M	-49.09%-12.57M	-119.99%-19.96M
Investing cash flow
Cash flow from continuing investing activities	-201.26%-30.38M	200.15%30M	0	0	0	151.70%30M	-383,637.25%-29.95M	27M	19.02M	-17.94M
Net PPE purchase and sale	----	--0	--0	--0	----	----	-109.03%-16.32K	--0	--0	--0
Net investment purchase and sale	-201.26%-30.38M	200.21%30M	--0	--0	--0	151.71%30M	---29.94M	--27M	--19.02M	---17.94M
Cash from discontinued investing activities
Investing cash flow	-201.26%-30.38M	200.15%30M	--0	--0	--0	151.70%30M	-383,637.25%-29.95M	--27M	--19.02M	---17.94M
Financing cash flow
Cash flow from continuing financing activities	-65.39%18.19K	-204.11%-1.27M	-1.01M	-126.38%-315.76K	5.29K	125.34%52.56K	-99.37%1.22M	0	1,776.46%1.2M	0
Proceeds from stock option exercised by employees	-65.39%18.19K	-74.98%305.23K	--30.19K	-81.85%217.19K	--5.29K	125.34%52.56K	-73.96%1.22M	--0	1,776.46%1.2M	--0
Net other financing activities	----	---1.58M	---1.04M	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-65.39%18.19K	-204.11%-1.27M	---1.01M	-126.38%-315.76K	--5.29K	125.34%52.56K	-99.37%1.22M	--0	1,776.46%1.2M	--0
Net cash flow
Beginning cash position	-1.11%142.82M	-37.15%144.42M	11.41%143.33M	25.34%151.68M	3.85%165.03M	-37.15%144.42M	195.14%229.79M	-46.70%128.65M	-51.54%121.01M	14.78%158.91M
Current changes in cash	-295.70%-40.33M	98.13%-1.6M	-103.25%-511.87K	-209.19%-8.34M	64.77%-13.35M	129.07%20.61M	-156.19%-85.37M	236.20%15.77M	191.26%7.64M	-134.05%-37.9M
End cash Position	-37.89%102.49M	-1.11%142.82M	-1.11%142.82M	11.41%143.33M	25.34%151.68M	3.85%165.03M	-37.15%144.42M	-37.15%144.42M	-46.70%128.65M	-51.54%121.01M
Free cash flow	-5.60%-9.97M	46.47%-30.33M	104.46%500.44K	36.18%-8.02M	33.07%-13.36M	26.73%-9.44M	-33.10%-56.65M	2.99%-11.23M	-49.09%-12.57M	-119.99%-19.96M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall